CompaniesByCap
CBIO
Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare

Crescent Biopharma, Inc. Income Statement 2012–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2023Dec 2022Dec 2021Dec 2020Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012
Revenues
Revenue10.8M10,00075,0001.2M10.2M18,50020.1M15.0M4.0M15.3M
Gross Profit
Profitability
Operating Income-152.6M-39.3M-47.4M-63.4M-51.5M-31.9M-12.8M-11.1M-10.6M3.6M
EBITDA
Net Income-153.9M-36.9M-46.7M-63.4M-51.0M-31.8M-12.8M-11.1M-10.6M3.7M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)28M63M53M51M46M23M19M18M1M11M

Crescent Biopharma, Inc. Income Statement — FAQ

Crescent Biopharma, Inc. (CBIO) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CBIO's income statement history?

The chart and table above show Crescent Biopharma, Inc.'s income statement by year and by quarter, including the growth rate.